Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-enhancer of increased mortality during development | maternal effect phenotype of Fs(2)KetRP13, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-enhancer of increased mortality during development | maternal effect phenotype of Fs(2)KetRX13, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-enhancer of increased mortality during development | maternal effect phenotype of Fs(2)Ketc02473, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-enhancer of increased mortality during development | maternal effect phenotype of Fs(2)Kete02657, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-enhancer of increased mortality during development | maternal effect phenotype of Fs(2)Kete03750, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-suppressor of increased mortality during development | maternal effect phenotype of Fs(2)KetRP13, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-suppressor of increased mortality during development | maternal effect phenotype of Fs(2)KetRX13, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-suppressor of increased mortality during development | maternal effect phenotype of Fs(2)Ketc02473, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-suppressor of increased mortality during development | maternal effect phenotype of Fs(2)Kete02657, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp is a non-suppressor of increased mortality during development | maternal effect phenotype of Fs(2)Kete03750, PenD14
Scer\GAL4VP16.nanos.UTR/PenΔIBB.UASp partially rescues PenD14
Scer\GAL4c747/PenΔIBB.UASp fails to rescue PenmbmB
Expression of PenΔIBB.Scer\UAS.P\T under the control of Scer\GAL4nos.UTR.T:Hsim\VP16 in PenD14 females restores egg laying to an average of 12.0 eggs/day. However, 86% of the eggs have abnormally fused dorsal appendages, approximately 10% are shorter than normal and none of the eggs hatch. 27% of ring canals in the ovary are fully occluded by actin.